期刊文献+

免疫抑制剂等药物局部注射治疗甲状腺功能亢进的疗效及安全性研究 被引量:9

Investigation on the efficacy and safety of localized intrathyroid injection of immunosuppressive agents in treatment of hyperthyroidism
暂未订购
导出
摘要 目的 探讨甲状腺局部注射免疫抑制剂地塞米松 (Dex)、环磷酰胺 (CTX)、环孢素A(CysA)、生长抑素类似物奥曲肽及无水乙醇联合应用治疗甲状腺功能亢进 (甲亢 )的疗效及安全性。方法 采用随机单盲法将 310 0例甲状腺功能亢进患者分为 5组 :A组 :Dex局部注射 ;B组 :Dex、CTX和CysA局部注射 ;C组 :奥曲肽局部注射 ;D组 :Dex、CTX、CysA和奥曲肽局部注射 ;E组 :Dex、CTX、CysA、奥曲肽和无水乙醇局部注射。局部治疗每周 1次 ,连续 3个月 ;然后每 2周 1次 ,共 4次 ;再改为每月 1次 ,共 2个月 ,观察甲状腺体积和功能、肝、肾功能及血、尿常规改变。结果 免疫抑制剂等药物局部治疗均可使甲状腺体积明显缩小 ,以E组最显著 ,治疗过程中肝、肾功能及血、尿常规无明显改变。 Objective To investigate the efficacy and safety of localized intra throid injection of dexamethasone(Dex), cyclophosphamide(CTX),cyclosporin A (CysA),sandostatin,ethanol in treatment of hyperthyroidism. Methods 3 100 patients with Graves' disease were randomly divided into 5 groups:① treated with Dex;②treated with Dex,CTX and CysA;③treated with sandostatin;④treated with Dex ,CTX,CysA and sandostatin;⑤treated with Dex ,CTX,CysA ,sandostatin and ethanol . Immunosuppressive agents were injected locally once a week for 3 months, then once for two months and once a month for 2 months. The changes of the thyroid volume, plasma T3 and T4 level, liver and kidney functions and blood routine were examined. Results Regression of enlargement of thyroid was obtained significantly after the local treatment, especially in group 5. The liver and kidney functions with, blood routine showed no change. Conclusion The localized intrathyroid injection of immunosuppressive agents is safe and effective in the treatment of Graves' disease.
出处 《上海医学》 CAS CSCD 北大核心 2003年第1期18-20,共3页 Shanghai Medical Journal
关键词 安全性 甲状腺功能亢进症 免疫抑制剂 治疗 注射 Hyperthyroidism Immunosuppressive agents Injection
  • 相关文献

参考文献8

  • 1Torre G, Barreca A, Borgonovo G, et al. Goiter recurrence in patients submitted to thyroid-stimulating hormone suppression: possible role of insulin-like growth factors and insulin-like growth factorbinding proteins. Surgery,2000 , 127:99-103.
  • 2Marti U, Ruchti C, Kampf J,et al. Nuclear localization of epidermal growth factor and epidermal growth factor receptors in human thyroid tissues. Thyroid, 2001,11:137-145.
  • 3McGregor AM,Beck L,Hall R. Cyclosporin A in management of Graves' disease. J R Soc Med, 1985,78: 511-512.
  • 4刘志民,顾明君,邹俊杰,许金廉,石勇铨,沈玉美,谈雯,林朗,段继才.免疫抑制剂局部注射治疗弥漫性甲状腺肿伴甲亢的疗效观察[J].第二军医大学学报,2002,23(3):308-310. 被引量:25
  • 5顾明君,刘志民,朱莉,沈玉美,石勇铨,徐洁.奥曲肽和泼尼松治疗甲状腺相关性眼病的随机对照研究[J].第二军医大学学报,2002,23(5):540-543. 被引量:15
  • 6Brkljacic B,Sucic M, Bozikov V, et al. Treatment of autonomous and toxic thyroid adenomas by percutaneous ultrasound-guided ethanol injection. Acta Radiol, 2001,42: 477-481.
  • 7Del Prete S, Russo D, Caraglia M, et al. Percutaneous ethanol injection of autonomous thyroid nodules with a volume larger than 40ml: three years of follow-up. Clin Radiol,2001,56: 895-901.
  • 8Zingrillo M,Torlontano M,Chiarella R,et al. Percutaneous ethanol injection may be a definitive treatment for symptomatic thyroid cystic nodules not treatable by surgery: five-year follow-up study.Thyroid, 1999,9: 763-767.

二级参考文献2

共引文献36

同被引文献62

  • 1廖宁,黄丽莉,陈剑锋.大剂量甲氨喋呤治疗前后T淋巴细胞亚群及甲状腺功能检测[J].白血病,1995,4(3):165-166. 被引量:3
  • 2蒋琳,刘超.甲状腺疾病局部免疫调节治疗的研究进展[J].中国实用内科杂志,2005,25(9):851-853. 被引量:38
  • 3刘晓云,刘超,覃又文,武晓泓,蒋琳,孙敏,魏玲.慢性淋巴细胞性甲状腺炎的局部免疫调节治疗[J].江苏医药,2007,33(2):124-126. 被引量:13
  • 4江明性.药理学[M].北京:人民卫生出版社,1995,4.276.
  • 5顾明君 刘志民 等.地塞米松甲状腺注射治疗重度甲状腺功能亢进[J].药学实践,1994,7:42-43.
  • 6刘国志 邵惠梅.甲状腺局部注射治疗甲状腺功能亢进症及对皮质激素受体的影响[J].第二军医大学学报,2001,22(11):1095-1095.
  • 7Hsu SW, Chaloupka JC, Fattal D. Rapidly progressive fatal bihemispheric infarction secondary to Moyamoya syndromein association with Graves thyrotoxieosis[J]. AJNR Am J Neuroradiol, 2006,27(3):643--647.
  • 8Jurgilewicz DH, Rogowski F, Lebkowska U, et al. E-seleetin, L- selectin,ICAM-1 and IL-6 concentrations changes in the serum of patients with hyperthyroidism in the early period of radioiodine 1- 131 therapy[J]. Nuclear Medicine Review 2002,5 ( 1 ) : 39 -- 42.
  • 9Faber J, Wiinberg N, Schifter S, et al. Haemodynamic changes following treatment of subclinical and overt hyperthyroidism[J]. Eur J Endocrinol. , 2001,145(4) : 391 -- 396.
  • 10Verberne HJ, Fliers E, Prummel MF, et al. Thyrotoxicosis as a predisposing factor for cerebral venous thrombosis[J]. Thyroid, 2000,10(7):607-- 610.

引证文献9

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部